Abstract
Cardiovascular imaging techniques have advanced our understanding of the pathophysiology of acute and chronic myocardial infarction (MI). Infarct size is intimately related to adverse LV remodeling, heart failure and clinical outcomes (1,2). Rapid, robust, and reproducible quantification of infarct size is therefore desirable in both clinical and research settings. The late gadolinium enhancement (LGE) technique using cardiovascular magnetic resonance is the gold standard method because of its high spatial resolution and excellent contrast (3). The technique uses a chelated gadolinium contrast agent, which acts as an extracellular tracer. This accumulates in areas where cell membranes are not intact (cells destined to die in acute MI) or where there is replacement fibrosis (chronic MI). Gadolinium, which shortens T1, causes the infarct to appear bright (white) on a T1 weighted image (4). Infarction imaged in this way correlates accurately with histological specimens in ex vivo animal studies (3,5) and is prognostic in multiple human studies (1). It guides therapy and is used as a surrogate endpoint in many acute infarct trials.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
